How Does BrainsWay Deep TMS Work?

BrainsWay Deep TMS™ (Deep Transcranial Magnetic Stimulation) is a noninvasive treatment that uses magnetic pulses to stimulate targeted areas of the brain associated with certain mental health conditions. BrainsWay’s patented H-Coil technology is built into a comfortable helmet and is designed to reach broader and deeper areas of the brain than traditional TMS technology. In the U.S., BrainsWay Deep TMS has FDA-cleared indications that include major depressive disorder (MDD), obsessive-compulsive disorder (OCD), and smoking addiction.

During treatment, patients remain awake and seated comfortably while the helmet delivers magnetic pulses that help regulate activity in targeted brain regions. No anesthesia or hospitalization is required, and treatment sessions are typically about 20 minutes, allowing patients to return to their normal daily activities afterward. Deep TMS may be an option for people who have not experienced sufficient improvement with medications or psychotherapy.

Deeper & Broader Stimulation, Activating More Neurons

Deep TMS technology, unique to BrainsWay, enables non-invasive activation of deeper and broader brain structures thanfirst-generation figure 8-coil TMS systems, allowing the H-Coil to potentially address a wider range of neuropsychiatric conditions.

With all forms of TMS, the intensity of stimulation naturally decays as it reaches deeper into the brain. Our unique coil design allows for the strength of stimulation to be maintained at effective levels even in regions deeper within the brain that are affiliated with the indications we treat1.

For patients that are older, First-Generation TMS may not penetrate deep enough to generate a therapeutic effect, as in the case of late-life depression3

At A New Outlook Recovery Services, we offer BrainsWay Deep TMS—a non-invasive, FDA-cleared therapy designed for individuals experiencing depression that has not improved enough with traditional treatments such as medication or talk therapy.

How TMS Works

Deep TMS technology, unique to BrainsWay, enables non-invasive activation of deeper and broader brain structures thanfirst-generation figure 8-coil TMS systems, allowing the H-Coil to potentially address a wider range of neuropsychiatric conditions.

With all forms of TMS, the intensity of stimulation naturally decays as it reaches deeper into the brain. Our unique coil design allows for the strength of stimulation to be maintained at effective levels even in regions deeper within the brain that are affiliated with the indications we treat1.

For patients that are older, First-Generation TMS may not penetrate deep enough to generate a therapeutic effect, as in the case of late-life depression3.

TMS uses gentle, targeted magnetic pulses to stimulate areas of the brain involved in mood regulation. During treatment:

  • A small electromagnetic coil is placed comfortably against the scalp.
  • Controlled magnetic pulses activate underactive neural pathways linked to depression.
  • Over time, this stimulation can help reduce depressive symptoms and support emotional balance.
  • TMS is performed in-office, requires no anesthesia, and allows clients to return to normal daily activities immediately afterward.

PATIENT BROCHURE

DOWNLOAD BROCHURE

Why Many Clients Consider TMS

  • Non-invasive and drug-free
  • Minimal side effects compared to medication
  • Short sessions, typically 20–40 minutes
  • Safe for long-term or treatment-resistant depression
  • Can be used alongside ongoing therapy or medication management

Our clinical team evaluates each client to determine whether TMS is an appropriate and effective option based on symptoms, history, and treatment goals.

Try TMS – A Proven Alternative Treatment for Depression

PHQ-9 Depression Test

The 9-question Patient Health Questionnaire (PHQ-9) is a diagnostic tool introduced in 2001 to screen adult patients in a primary care setting for the presence and severity of depression.  It rates depression based on the self-administered Patient Health Questionnaire (PHQ).  The PHQ is part of Pfizer’s larger suite of trademarked products, called the Primary Care Evaluation of Mental Disorders (PRIME-MD).  The PHQ-9 takes less than 3 minutes to complete and simply scores each of the 9 DSM-IV criteria for depression based on the mood module from the original PRIME-MD.  Primary care providers frequently use the PHQ-9 to screen for depression in patients.